DFTX is Definium Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $38.90. Market cap: $5.17B.
Stock snapshot
| Price | $38.90 |
| Market cap | $5.17B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About DFTX
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.
Related non-dividend companies
Other non-dividend stocks investors research alongside DFTX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is DFTX's current stock price?
DFTX (Definium Therapeutics, Inc.) is currently trading at $38.90.
Does DFTX pay a dividend?
DFTX (Definium Therapeutics, Inc.) does not currently pay a regular dividend.
Track DFTX in DiviDrip
Add DFTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search DFTX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.